CLINICAL TRIALS AND OBSERVATIONS Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report
نویسندگان
چکیده
1Gaffin Center for Neuro-Oncology and Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel; 2Massachusetts General Hospital Cancer Center, Boston; 3Neuro-Oncology Unit, Daniel den Hoed Cancer Center/Erasmus University Medical Center, Rotterdam, The Netherlands; 4Department of Oncology, Sourasky Medical Center, Tel Aviv, Israel; 5Neuro-Oncology Center, University of Virginia, Charlottesville; 6Department of Oncology, Oulu University Hospital, Oulu, Finland; 7Department of Neurology, University of Washington, Seattle; 8Department of Neurology, University Hospital Zurich, Zurich, Switzerland; and 9Department of Hematology, Barzilai Medical Center, Ashkelon, Israel
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report Nancy D. Doolittle,1 Lauren E. Abrey,2 Tamara N. Shenkier,3 Tali Siegal,4 Jacoline E.C. Bromberg,5 Edward A. Neuwelt,1,6 Carole Soussain,7 Kristoph Jahnke,8 Patrick Johnston,9 Gerald Illerhaus,10 David Schiff,11 Tracy Batchelo...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents Mitchell S. Cairo,1 Mary Gerrard,2 Richard Sposto,3 Anne Auperin,4 C. Ross Pinkerton,5 Jean Michon,6 Claire Weston,7 Sherrie L. Perkins,8 Martine Raphael,9 Keith McCarthy,10 and Catherine Patte,4 on behalf of the FAB LMB96 Internat...
متن کاملHigh-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen.
R elapse of systemic lymphoma within the central nervous system (CNS) is a devastating event with very few long-term survivors after treatment with conventional therapy. High-dose chemotherapy employing CNS-penetrating agents with autologous stem cell support has demonstrated promise in prospective trials in primary CNS lymphoma, 1 and so has naturally gar-nered attention in secondary CNS lymph...
متن کاملCLINICAL TRIALS AND OBSERVATIONS CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
One thousand two hundred twenty-two patients treated in the Rituximab with CHOP over age 60 years (RICOVER-60) trial were examined for central nervous system (CNS) disease developing during first-line therapy or after a complete or partial remission had been achieved. Patients received 6 or 8 courses of CHOP (cyclophosphamide, adriamycin, vincristine, prednisone) administered every 2 weeks (CHO...
متن کاملRegular Article CLINICAL TRIALS AND OBSERVATIONS Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma
1Division of Hematology/Oncology and 2Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA; 3Genentech, South San Francisco, CA; 4Medical Oncology, Stanford University, Stanford, CA; 5Department of Neuro-oncology, Dana-Farber Cancer Center, Boston, MA; 6Department of Neuro-oncology, Massachusetts General Hospital, Boston, MA; 7Department of Neuro-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010